Ferroptosis-inhibitor drug developer (apoethylmorphine)
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Seed Japanese biotech CureCell ran an equity crowdfunding pre-Series A round on Ecrowd, raising up to JPY 50m for preclinical trials of its ferroptosis-inhibitor drug. | $323K |